| 2026-05-18 |
详情>>
内部人交易：
Charles Faith L.股份增加7100.00股
|
| 2026-05-14 |
详情>>
股本变动：
变动后总股本146.14万股
|
| 2026-05-14 |
详情>>
业绩披露：
2026年一季报每股收益-7.3美元,归母净利润-493.7万美元,同比去年增长-14.78%
|
| 2026-03-31 |
详情>>
业绩披露：
2025年年报每股收益-35.75美元,归母净利润-1585.06万美元,同比去年增长-6.68%
|
| 2026-01-15 |
复牌提示：
2026-01-15 09:32:32 停牌，复牌日期 2026-01-15 09:44:48
|
| 2025-11-14 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-25.6美元,归母净利润-989.48万美元,同比去年增长15.29%
|
| 2025-10-24 |
股东大会：
将于2025-11-17召开股东大会
会议内容 ▼▲
- 1.To elect six Board nominees to the Board of Directors of the Company, each to serve until the 2026 annual meeting of stockholders of the Company or until such person’s successor is qualified and elected.
2.To ratify the appointment of MaloneBailey, LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2025.
3.To vote on a non-binding, advisory resolution to approve executive compensation.
4.To vote on a non-binding, advisory proposal on the frequency of holding future votes regarding executive compensation.
5.To approve an amendment to the Company’s Amended and Restated Articles of Incorporation to increase the total number of authorized shares of common stock from 25,000,000 shares to 300,000,000 shares and the total number of authorized shares of preferred stock from 416,667 shares to 5,000,000 shares.
6.To approve amendments to the Company’s 2020 Stock Plan including an increase in the number of shares of common stock authorized for issuance under the Company’s 2020 Stock Plan.
7.To authorize the adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the Annual Meeting or adjournment or postponement thereof to approve any of the above proposals.
|
| 2025-08-14 |
详情>>
业绩披露：
2025年中报每股收益-22.35美元,归母净利润-667.63万美元,同比去年增长-9.89%
|
| 2025-07-18 |
详情>>
拆分方案：
每12.0000合并分成1.0000股
|
| 2025-05-15 |
详情>>
业绩披露：
2025年一季报每股收益-1.58美元,归母净利润-430.13万美元,同比去年增长-21.34%
|
| 2025-03-31 |
详情>>
业绩披露：
2024年年报每股收益-38.87美元,归母净利润-1485.78万美元,同比去年增长21.18%
|
| 2025-02-21 |
详情>>
拆分方案：
每50.0000合并分成1.0000股
|
| 2024-11-14 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-1.54美元,归母净利润-1168.14万美元,同比去年增长13.32%
|
| 2024-10-28 |
股东大会：
将于2024-11-26召开股东大会
会议内容 ▼▲
- 1.To grant our Board of Directors authority, in its sole discretion, prior to the one-year anniversary of this Special Meeting, to effect a reverse stock split of the outstanding shares of the Company’s common stock, at a reverse split ratio of between 1-for-2 and 1-for-50 as determined by the Board of Directors, by the filing of an amendment to the Company's Amended and Restated Articles of Incorporation (collectively, the “Reverse Stock Split Proposal”).
2.To approve, for purposes of complying with Nasdaq Listing Rule 5635(d), the repricing of warrants issued to investors to purchase an aggregate of 2,434,120 shares of common stock with exercise prices ranging from $1.26 to $15.00 per share (the “Investor Warrants”), so that each of the Investor Warrants has a new exercise price equal to the lower of (i) $1.13 per share or (ii) the closing price of the Company common stock on the date when the stockholders of the Company approve the repricing of the Investor Warrants (the “Warrant Repricing Proposal”).
3.To authorize the adjournment of the Special Meeting, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the Special Meeting or adjournment or postponement thereof to approve the Reverse Stock Split Proposal and/or the Warrant Repricing Proposal.
|
| 2024-08-14 |
详情>>
业绩披露：
2024年中报每股收益-22.08美元,归母净利润-607.55万美元,同比去年增长32.14%
|
| 2024-06-05 |
详情>>
拆分方案：
每50.0000合并分成1.0000股
|
| 2024-05-15 |
详情>>
业绩披露：
2024年一季报每股收益-0.41美元,归母净利润-354.47万美元,同比去年增长28.13%
|
| 2024-04-10 |
股东大会：
将于2024-04-30召开股东大会
会议内容 ▼▲
- 1.To elect six Board nominees to the Board of Directors of the Company, each to serve until the 2025 annual meeting of stockholders of the Company or until such person’s successor is qualified and elected.
2.To ratify the appointment of MaloneBailey, LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2024.
3.To grant our Board of Directors authority, in its sole discretion, prior to the one-year anniversary of this Annual Meeting, to effect a reverse stock split of the outstanding shares of the Company’s common stock, at a reverse split ratio of between 1-for-2 and 1-for-50 as determined by the Board of Directors, by the filing of an amendment to the Company's Amended and Restated Articles of Incorporation.
4.To approve an amendment to the Company’s Amended and Restated Articles of Incorporation to increase the total number of authorized shares of common stock from 75,000,000 shares to 300,000,000 shares.
5.To approve amendments to the Company's 2020 Stock Plan including an increase in the number of shares of common stock authorized for issuance under the Company's 2020 Stock Plan.
6.To approve, for purposes of complying with Nasdaq Listing Rule 5635(d), the repricing of certain warrants to purchase up to 3,756,000 shares of common stock issued on October 16, 2023, from $1.28 per share to $0.30 per share and to extend the termination date of such warrants to February 1, 2029.
7.To authorize the adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the Annual Meeting or adjournment or postponement thereof to approve any of the above proposals.
|
| 2024-04-01 |
详情>>
业绩披露：
2023年年报每股收益-5美元,归母净利润-1885.12万美元,同比去年增长-23.42%
|
| 2023-08-14 |
股东大会：
将于2023-09-14召开股东大会
会议内容 ▼▲
- 1.To elect seven Board nominees to the Board of Directors of the Company, each to serve until the 2024 annual meeting of stockholders of the Company or until such person’s successor is qualified and elected.
2.To ratify the appointment of MaloneBailey, LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2023.
3.To approve amendments to the Company's 2020 Stock Plan including an increase in the number of shares of common stock authorized for issuance under the Company's 2020 Stock Plan.
|
| 2022-11-29 |
详情>>
拆分方案：
每30.0000合并分成1.0000股
|
| 2022-07-07 |
股东大会：
将于2022-07-27召开股东大会
会议内容 ▼▲
- 1.To elect five Board nominees to the Board of Directors of the Company, each to serve until the 2023 annual meeting of stockholders of the Company or until such person’s successor is qualified and elected.
2.To ratify the appointment of MaloneBailey, LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2022.
3.To approve an amendment to the Company’s amended and restated articles of incorporation to effect a reverse stock split of the outstanding shares of the Company’s common stock, at a split ratio of between 1-for-2 and 1-for-30 as determined by the Board of Directors in its sole discretion, prior to the one-year anniversary of this Annual Meeting.
4.To authorize the adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the Annual Meeting or adjournment or postponement thereof to approve of the foregoing proposals.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-06-08 |
股东大会：
将于2021-06-28召开股东大会
会议内容 ▼▲
- 1.To elect five Board nominees to the Board of Directors of the Company, each to serve until the 2022 annual meeting of stockholders of the Company or until such person’s successor is qualified and elected.
2.To ratify the appointment of MaloneBailey, LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2021.
3.To approve, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of more than 20% of the Company’s issued and outstanding common stock pursuant to the Company’s purchase agreement with Lincoln Park Capital Fund, LLC.
|
| 2020-04-24 |
股东大会：
将于2020-06-08召开股东大会
会议内容 ▼▲
- 1.To elect five Board nominees to the Board of Directors of the Company, each to serve until the 2021 annual meeting of stockholders of the Company or until such person’s successor is qualified and elected.
2.To ratify the appointment of MaloneBailey, LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2020.
3.To approve the Company’s 2020 Equity Plan.
4.To transact any other business that is properly brought before the Annual Meeting or any adjournment or postponement thereof.
|